WHO ICTRP trial
Effect of platelet activating factor receptor antagonist on acute ischemic and…
ITMCTR2100004815 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2100004815 |
|---|---|
| Public title | Effect of platelet activating factor receptor antagonist on acute ischemic and its anti-thrombotic and anti-inflammatory mechanism |
| Scientific title | Effect of platelet activating factor receptor antagonist on acute ischemic and its anti-thrombotic and anti-inflammatory mechanism:a case-control study |
| Primary sponsor | Zhaoqing First People's Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | acute ischemic stroke |
| Interventions | conventional group:conventional antiplatelet;Ginkgo diterpene lactones group:Ginkgo diterpene lactones gluamine injection |
| Registration date | Jan 24, 2021 |
| Target size | conventional group:100;Ginkgo diterpene lactones group:100 |
| Secondary IDs | ChiCTR2100042628;ChiMCTR2100004815 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: